# Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes

Study · id `cardio:ct-nct01633177` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01633177](<https://clinicaltrials.gov/study/NCT01633177>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01633177

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 22220 participants.

## Technical summary

Registry record NCT01633177. Randomized; triple masking; primary purpose prevention. Start 2011-11 (actual); primary completion 2024-05-30 (actual). Results posted on 2026-04-03.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 3
- Enrolled: 22220 participants (enrolled count; ClinicalTrials.gov record NCT01633177, source copy `cardio:ctgov-nct01633177-2026-04-03`, retrieved 2026-10-26)
- Started: 2011-11 (actual) (ClinicalTrials.gov record NCT01633177, source copy `cardio:ctgov-nct01633177-2026-04-03`, retrieved 2026-10-26)
- Primary completion: 2024-05-30 (actual) (ClinicalTrials.gov record NCT01633177, source copy `cardio:ctgov-nct01633177-2026-04-03`, retrieved 2026-10-26)
- Completion: 2024-05-30 (actual) (ClinicalTrials.gov record NCT01633177, source copy `cardio:ctgov-nct01633177-2026-04-03`, retrieved 2026-10-26)
- Results first posted: 2026-04-03 (ClinicalTrials.gov record NCT01633177, source copy `cardio:ctgov-nct01633177-2026-04-03`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01633177, source copy `cardio:ctgov-nct01633177-2026-04-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01633177-2026-04-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study of Vitamin D and Omega-3 Supplementation for Preventing Diabetes
- Condition: Type 2 Diabetes
- Intervention (Dietary supplement): Vitamin D3
- Intervention (Drug): Omega-3 fatty acid (fish oil)
- Intervention (Dietary supplement): Vitamin D3 placebo
- Intervention (Drug): Fish oil placebo
- Lead sponsor: Brigham and Women's Hospital
- Lead sponsor class: OTHER
- Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as the lead sponsor: Brigham and Women's Hospital (`cardio:org-brigham-and-women-s-hospital`)
- Registry lists this organization as a collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (`cardio:niddk`)

## Provenance

Content hash: cfb234f6c5652823c924c22aca3d6565e6ccc8dd391ceae7afb4e5200eb36650
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
